Related Experiment Video
Updated: Aug 11, 2026

A Cre-Lox P Recombination Approach for the Detection of Cell Fusion In Vivo
Published on: January 4, 2012
[First advances in molecular endocrinology obtained using the Cre/LoxP system]
1yuri-pankov@mtu-net.ru
Abstract:
The insulin-like growth factor I (IGF-I) is produced in the liver and is considered mediating the effect of the growth hormone (GH). However, a knock-out only in liver IGF-I slightly disturbs the growth and development of mice. Such mice develop insulin resistance of various organs, including muscles. A knock-out in the liver insulin gene also results in insulin resistance. Selective inactivation of the gene for glucokinase (a target of insulin) in pancreatic islets or in the liver suppresses insulin secretion in the pancreas.
Insights
Liver-produced insulin-like growth factor I (IGF-I) plays a role in growth and insulin sensitivity. Disrupting liver IGF-I or insulin genes can lead to insulin resistance in mice.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Genetics
Context:
- Insulin-like Growth Factor I (IGF-I), primarily produced in the liver, mediates Growth Hormone (GH) effects.
- Liver-specific IGF-I knockout mice exhibit mild growth disturbances but develop significant insulin resistance.
- Insulin resistance is also observed in mice with liver-specific insulin gene knockout.
Purpose:
- To investigate the role of liver-derived IGF-I in overall growth and metabolic regulation.
- To explore the impact of genetic modifications in the liver on insulin sensitivity.
- To understand the function of glucokinase in pancreatic insulin secretion.
Summary:
- Liver-specific knockout of IGF-I in mice leads to insulin resistance in multiple organs, including muscles, despite only slightly affecting growth.
- Knocking out the insulin gene in the liver also results in insulin resistance.
- Selective inactivation of glucokinase, an insulin target, in pancreatic islets or the liver impairs insulin secretion.
Impact:
- Highlights the critical role of the liver in IGF-I production and its contribution to systemic insulin sensitivity.
- Provides insights into the complex interplay between growth hormone, IGF-I, insulin, and glucose metabolism.
- Suggests potential therapeutic targets for metabolic disorders related to insulin resistance and impaired insulin secretion.
More Related Videos
Related Concept Videos
Endocrine Signaling
Transgenic Organisms
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

